Since anti-CD73 antibody did not block tumor growth in A2AR-deficient mice (84), it is likely that adenosine produced from CD73-expressing tumor cells suppresses antitumor immune response in an A2AR-dependent fashion. The gene discussed is NT5E; the disease is neoplasm.